NUDT5 and breast carcinoma: To evaluate the possibility of utilizing NUDT5 as a prognostic factor, Zhang et al. [36] found that NUDT5 is highly expressed in breast cancer specimens, and patients with high NUDT5 expression have worse clinical outcomes.